Elutia (ELUT) EBIT Growth (3y) (2022 - 2026)
Powered by 
Analysis
Elutia (ELUT) EBIT Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn | 13.06% |
| 10 | Elutia | 34.72 Mn | 14.83 Mn | 1.45 Mn | -8.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.04% |
| Mar 31, 2026 | 8.69% |
| Dec 31, 2025 | 11.69% |
| Sep 30, 2025 | 16.57% |
| Jun 30, 2025 | -0.74% |
| Mar 31, 2025 | 0.70% |
| Dec 31, 2024 | 1.32% |
| Sep 30, 2024 | -9.56% |
| Jun 30, 2024 | -22.80% |
| Mar 31, 2024 | -31.85% |
| Dec 31, 2023 | -29.00% |
| Sep 30, 2023 | -39.92% |
| Jun 30, 2023 | -18.80% |
| Mar 31, 2023 | -37.87% |
| Dec 31, 2022 | -43.72% |
| Sep 30, 2022 | -69.33% |